- Home
- CLDI vs SDOT Comparison
CLDI vs SDOT Comparison
Compare CLDI & SDOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDI
- SDOT
- Stock Information
- Founded
- CLDI 2014
- SDOT 2014
- Country
- CLDI United States
- SDOT United States
- Employees
- CLDI N/A
- SDOT N/A
- Industry
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- SDOT Restaurants
- Sector
- CLDI Health Care
- SDOT Consumer Discretionary
- Exchange
- CLDI Nasdaq
- SDOT Nasdaq
- Market Cap
- CLDI 20.2M
- SDOT 8.0M
- IPO Year
- CLDI N/A
- SDOT 2020
- Fundamental
- Price
- CLDI $1.59
- SDOT $7.82
- Analyst Decision
- CLDI
- SDOT
- Analyst Count
- CLDI 0
- SDOT 0
- Target Price
- CLDI N/A
- SDOT N/A
- AVG Volume (30 Days)
- CLDI 473.3K
- SDOT 28.7K
- Earning Date
- CLDI 11-11-2025
- SDOT 11-11-2025
- Dividend Yield
- CLDI N/A
- SDOT N/A
- EPS Growth
- CLDI N/A
- SDOT N/A
- EPS
- CLDI N/A
- SDOT 6.14
- Revenue
- CLDI N/A
- SDOT $667,695,000.00
- Revenue This Year
- CLDI N/A
- SDOT $12.76
- Revenue Next Year
- CLDI N/A
- SDOT $5.54
- P/E Ratio
- CLDI N/A
- SDOT $1.26
- Revenue Growth
- CLDI N/A
- SDOT 7.00
- 52 Week Low
- CLDI $1.51
- SDOT $7.00
- 52 Week High
- CLDI $46.68
- SDOT $57.00
- Technical
- Relative Strength Index (RSI)
- CLDI 30.54
- SDOT 40.20
- Support Level
- CLDI $1.51
- SDOT $7.00
- Resistance Level
- CLDI $1.68
- SDOT $8.25
- Average True Range (ATR)
- CLDI 0.09
- SDOT 0.69
- MACD
- CLDI 0.15
- SDOT -0.07
- Stochastic Oscillator
- CLDI 32.00
- SDOT 20.50
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
About SDOT Sadot Group Inc.
Sadot Group Inc operates in the food supply chain sector, connecting producers and consumers across the globe, delivering agri-commodities from producing geographies such as the Americas, Africa, and the Black Sea to consumer markets in Southeast Asia, China and the Middle East/North Africa (MENA) region. Its reportable segment includes Sadot food service and Sadot agri-foods. The key revenue is coming from the Sadot agri-foods segment which engaged in farming, commodity trading, and shipping of food and feed.